Neurocognitive Manifestations of Human Immunodeficiency Virus (Q45723465)

15 December 2017

title

Neurocognitive Manifestations of Human Immunodeficiency Virus (English)

1 reference

15 December 2017

Robert H Paul

1

1 reference

15 December 2017

Ronald A Cohen

series ordinal

2

1 reference

15 December 2017

Robert A Stern

series ordinal

3

1 reference

15 December 2017

publication date

1 December 2002

1 reference

15 December 2017

1 reference

15 December 2017

volume

7

1 reference

15 December 2017

issue

12

1 reference

15 December 2017

page(s)

860-866

1 reference

Incidence of AIDS dementia in a two-year follow-up of AIDS and ARC patients on an initial phase II AZT placebo-controlled study: San Diego cohort

15 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900022471

Neuronal loss in the hippocampus in Huntington's disease: a comparison with HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900022471

Cerebral white matter changes in acquired immunodeficiency syndrome dementia: alterations of the blood-brain barrier

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900022471

Neuronal number and volume alterations in the neocortex of HIV infected individuals.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900022471

Dendritic injury is a pathological substrate for human immunodeficiency virus-related cognitive disorders. HNRC Group. The HIV Neurobehavioral Research Center

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900022471

Progression to AIDS: the effects of stress, depressive symptoms, and social support

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900022471

Psychiatric disorder in HIV infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900022471

Neuropsychiatric aspects of HIV infection among older adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900022471

Mood disorders in HIV infection: prevalence and risk factors in a nonepicenter of the AIDS epidemic.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900022471

Predictors of nonadherence to HIV-related medication regimens during methadone stabilization

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900022471

Selective versus universal antenatal HIV testing: epidemiological and implementational factors in policy choice

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900022471

Predictors of self-reported adherence in persons living with HIV disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900022471

Neuropsychological impairment in human immunodeficiency virus-infection: implications for employment. HNRC Group. HIV Neurobehavioral Research Center

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900022471

Antiretroviral therapy in adults: updated recommendations of the International AIDS Society-USA Panel

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900022471

Selective serotonin reuptake inhibitor treatment of depression in symptomatic HIV infection and AIDS. Improvements in affective and somatic symptoms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900022471

HIV seroincidence among patients at clinics for sexually transmitted diseases in nine cities in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900022471

AIDS dementia-related psychosis: is there a window of vulnerability?

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900022471

High incidence of HIV-1 in South Africa using a standardized algorithm for recent HIV seroconversion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900022471

Effect of imipramine on mood and enumerative measures of immune status in depressed patients with HIV illness.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900022471

Apathy and depressed mood in acquired brain damage: relationship to lesion localization and psychophysiological reactivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900022471

Apathy, depression, and cognitive performance in HIV-1 infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900022471

21 January 2018

Apathy is not depression

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900022471

The sources of convergence between measures of apathy and depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900022471

Depressive symptoms decline among persons on HIV protease inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900022471

Neurocognitive and psychological contributions to quality of life in HIV-1-infected women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900022471

Mild cognitive impairment and risk of mortality in HIV-1 infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900022471

White matter abnormalities in HIV-1 infection: a diffusion tensor imaging study

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900022471

Basal ganglia metabolite abnormalities in minor motor disorders associated with human immunodeficiency virus type 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900022471

Elevated subcortical choline metabolites in cognitively and clinically asymptomatic HIV+ patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900022471

Neurocognitive performance enhanced by highly active antiretroviral therapy in HIV-infected women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900022471

Influence of cognitive reserve on neuropsychological functioning in asymptomatic human immunodeficiency virus-1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900022471

Neuropsychological performance in HIV-1-infected homosexual men: The Multicenter AIDS Cohort Study (MACS)

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900022471

Quality of Life in Persons with Human Immunodeficiency Virus Infection: Measurement by the Medical Outcomes Study Instrument

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900022471

Cytokines in the brain during viral infection: clues to HIV-associated dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900022471

In vivo emergence of HIV-1 variants resistant to multiple protease inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900022471

An inhibitor of HIV-1 protease modulates proteasome activity, antigen presentation, and T cell responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900022471

Depressive symptoms reduced in individuals with HIV/AIDS treated with highly active antiretroviral therapy: a longitudinal study

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900022471

Profile of central nervous system pathology in patients with AIDS: an autopsy study from India

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900022471

The brain in AIDS: central nervous system HIV-1 infection and AIDS dementia complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900022471

Neuropathology of Human Immunodeficiency Virus Infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900022471

HIV-1-associated central nervous system dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900022471

Neurobehavioral functioning in asymptomatic HIV-1 infected women

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900022471

The impact of protease inhibitor-containing highly active antiretroviral therapy on progression of HIV disease and its relationship to CD4 and viral load

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900022471

Neurobehavioral functioning in a nonconfounded group of asymptomatic HIV-seropositive homosexual men

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900022471

7 January 2021

Depression in patients with HIV infection.

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900022471

7 January 2021

Highly active antiretroviral treatment in HIV infection: benefits for neuropsychological function.

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900022471

7 January 2021

Relationships among apathy, depression, and cognitive impairment in HIV/AIDS.

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900022471

7 January 2021

Severe life stress as a predictor of early disease progression in HIV infection

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900022471

7 January 2021

Stress, social support, and distress in a statewide population of persons with AIDS in New Jersey

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900022471

7 January 2021

Depressive and anxiety disorders in women with HIV infection

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900022471

7 January 2021

Executive functioning and compliance in HIV patients

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900022471

7 January 2021

An overview of AIDS dementia complex

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900022471

7 January 2021

Changes in depressive symptoms as AIDS develops. The Multicenter AIDS Cohort Study

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900022471

7 January 2021

The impact of HIV-related neuropsychological dysfunction on driving behavior. The HNRC Group

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900022471

7 January 2021

Neurologic manifestations of AIDS.

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900022471

7 January 2021

Positive and sustained effects of highly active antiretroviral therapy on HIV-1-associated neurocognitive impairment

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900022471

7 January 2021

Changes in cerebral metabolism are detected prior to perfusion changes in early HIV-CMC: A coregistered (1)H MRS and SPECT study

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900022471

7 January 2021

Psychomotor slowing in HIV infection: a predictor of dementia, AIDS and death

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900022471

7 January 2021

Cerebral metabolic change in patients with AIDS: report of a six-month follow-up using positron-emission tomography

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900022471

7 January 2021

Low Education as a Possible Risk Factor for Cognitive Abnormalities in HIV-1

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900022471

7 January 2021

Neuropsychological abnormalities among HIV-infected individuals in a community-based sample.

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900022471

7 January 2021

10.1017/S1092852900022471

Identifiers

DOI

1 reference

15 December 2017

1 reference